Latest filing published 19 Mar 2024 for GeneDx Holdings Corp..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kareem Saad: trading record in brief
Kareem Saad is a declared insider of GeneDx Holdings Corp. (senior executive), with filings sourced from SEC (Form 4). Between 25 October 2021 and 18 March 2024, the trades on record add up to 55 filings.
Every open-market trade on record is a sale: 27 sales worth €233k. Outside the open market, there are 2 share grants and 26 option exercises. In 2024 alone, the filings show no purchases and 4 sales.
The newest entry dates from 19 March 2024: an open-market sale of €20k, in GeneDx Holdings Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kareem Saad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,114 shares0Class A Common StockSEC:0001415889-24-008502:0
- 897 shares@ US$9.209596.8% of flowClass A Common StockSEC:0001415889-24-007805:0
- 2,841 shares0Class A Common StockSEC:0001415889-24-007681:0
- 546 shares0Class A Common StockSEC:0001415889-24-001671:0
- 105 shares@ US$2.57993.2% of flowClass A Common StockSEC:0001209191-24-000840:0
- 273 shares0Class A Common StockSEC:0001209191-24-000376:0
- 5,114 shares0Class A Common StockSEC:0001209191-23-059289:0
- 2,841 shares0Class A Common StockSEC:0001209191-23-058263:0
- 546 sharesClass A Common StockSEC:0001209191-23-053359:0
- 273 sharesClass A Common StockSEC:0001209191-23-051462:0
- 5,114 sharesClass A Common StockSEC:0001209191-23-050053:0
- 2,841 sharesClass A Common StockSEC:0001209191-23-049135:0
- 546 sharesClass A Common StockSEC:0001209191-23-043166:0
- 273 sharesClass A Common StockSEC:0001209191-23-041207:0
- 5,114 sharesClass A Common StockSEC:0001209191-23-038751:0
- 2,841 sharesClass A Common StockSEC:0001209191-23-036824:0
- 9,005 sharesClass A Common StockSEC:0001209191-23-026074:0
- 18,014 sharesClass A Common StockSEC:0001209191-23-025203:0
- 9,005 sharesClass A Common StockSEC:0001209191-23-023006:0
- 93,750 sharesClass A Common StockSEC:0001209191-23-018275:0
- 18,014 sharesClass A Common StockSEC:0001209191-23-004477:0
- 3,170 shares@ US$0.26250.8% of flowClass A Common StockSEC:0001209191-23-002122:0
- 9,005 sharesClass A Common StockSEC:0001209191-23-001448:0
- 18,014 sharesClass A Common StockSEC:0001209191-22-054258:0
- 9,005 sharesClass A Common StockSEC:0001209191-22-052572:0
25 of 31 declarations
